Tandem Diabetes Care (TNDM) Total Current Liabilities (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Total Current Liabilities for 14 consecutive years, with $253.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Current Liabilities rose 0.52% year-over-year to $253.0 million; the trailing twelve-month figure through Jun 2026 stood at $253.0 million (up 0.52% YoY), and the FY2025 full-year result was $242.7 million, down 1.75% from the prior year.
• Total Current Liabilities advanced to $253.0 million in Q2 2026 per TNDM's latest filing, from $248.0 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $288.2 million in Q1 2025 and bottomed at $131.8 million in Q1 2022.
• Historically, Total Current Liabilities has averaged $211.9 million across 5 years, with a median of $217.9 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Total Current Liabilities soared 49.34% in 2025, then fell 13.96% in 2026.
• Over 5 years, Total Current Liabilities stood at $165.3 million in 2022, then advanced by 18.13% to $195.3 million in 2023, then advanced by 26.52% to $247.0 million in 2024, then dropped by 1.75% to $242.7 million in 2025, then advanced by 4.24% to $253.0 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $253.0 million, $248.0 million, and $242.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.